IRIS - Res&Arch Institutional Research Information System - Research & Archive

MOMI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.326
EU - Europa 1.082
AS - Asia 330
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 2.741
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.322
IE - Irlanda 270
UA - Ucraina 248
IT - Italia 197
HK - Hong Kong 134
SE - Svezia 116
VN - Vietnam 83
CN - Cina 73
RU - Federazione Russa 61
FI - Finlandia 59
DE - Germania 49
GB - Regno Unito 35
SG - Singapore 14
FR - Francia 13
TR - Turchia 11
BE - Belgio 7
CH - Svizzera 6
UZ - Uzbekistan 5
AT - Austria 4
LB - Libano 4
CA - Canada 3
PL - Polonia 3
RO - Romania 3
BG - Bulgaria 2
ES - Italia 2
GR - Grecia 2
KR - Corea 2
PH - Filippine 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
CR - Costa Rica 1
EU - Europa 1
IN - India 1
MK - Macedonia 1
NL - Olanda 1
NO - Norvegia 1
TW - Taiwan 1
Totale 2.741
Salva come PNG Salva come JPEG
Città #
Chandler 326
Dublin 265
San Mateo 146
Jacksonville 139
Hong Kong 134
Dong Ket 83
Perugia 78
Altamura 77
Medford 63
Princeton 63
Lawrence 57
Ann Arbor 51
Wilmington 51
Beijing 32
Andover 29
Des Moines 27
Saint Petersburg 21
Dearborn 17
San Paolo di Civitate 12
Woodbridge 12
Izmir 11
New York 10
Los Angeles 9
Norwalk 9
Ashburn 7
Boardman 7
Brussels 7
Helsinki 7
Auburn Hills 4
Falls Church 4
Moscow 4
Singapore 4
Amelia 3
Menlo Park 3
Ottawa 3
Rome 3
Shanghai 3
Southwark 3
Granarolo dell'Emilia e Viadagola 2
Gubbio 2
Houston 2
Ludwigshafen 2
Madrid 2
Narni 2
Newton Stewart 2
Parma 2
Redwood City 2
San Diego 2
Seoul 2
Siegen 2
Sofia 2
Timisoara 2
Ugong Norte 2
Alameda 1
Bucharest 1
Clearwater 1
Corciano 1
Den Haag 1
Falkenstein 1
Frankfurt Am Main 1
Fuzhou 1
Hebei 1
Kiev 1
Lausanne 1
Logan 1
London 1
New Orleans 1
Philadelphia 1
Redmond 1
San José 1
Taipei 1
Vancouver 1
Vijayawada 1
Wuhan 1
Zurich 1
Totale 1.836
Salva come PNG Salva come JPEG
Nome #
Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation. No effect of aspirin intake. 82
RhoA signaling through platelet P2Y1 receptor controls leukocyte recruitment in allergic mice. 81
Nitric oxide and its antithrombotic action on the cardiovascular system 77
Platelets are essential for leukocyte recruitment in allergic inflammation. 76
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. 74
Nitric oxide-donating aspirin (NCX 4016): an overview of its pharmacological properties and clinical perspectives. 66
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 66
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. 64
Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation 63
A novel mechanism regulating human platelet activation by MMP-2-mediated PAR1 biased signaling 63
Anti-platelet therapy: phosphodiesterase inhibitors. 62
Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. 60
Matrix metalloproteinases and peripheral arterial disease. 57
A novel nitric oxide-releasing statin derivative exerts and antiplatelet/antithrombotic activity and inhibits tissue factor expression. 57
Contribution of matrix metalloproteinase 2 to joint destruction in group B Streptococcus-induced murine arthritis. 57
Allergen induces the migration of platelets to lung tissue in allergic asthma. 55
Mechanisms of thrombocytopenia in platelet-type von Willebrand disease 55
Defective platelet beta-N-Acetyl hexosaminidase content and release in chronic myeloproliferative disorders 54
Endothelium, venous thromboembolism and ischaemic cardiovascular events. 52
Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders. 52
Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation. 49
Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis. 49
Established and new antiplatelet therapies 48
Matrix metalloproteinase-2 of human carotid atherosclerotic plaques promotes platelet activation. Correlation with ischaemic events. 47
Platelets contribute to the accumulation of matrix metalloproteinase type 2 in synovial fluid in osteoarthritis 47
Platelet Priming. 46
Visualization of nitric oxide production by individual platelets during adhesion in flowing blood. 46
Anti-platelet treatments in cancer: Basic and clinical research 46
AB0952 Intra-articular low molecular weight hyaluronate reduces platelet influx and matrix metalloproteinase-2 levels in synovial fluid of patients with knee osteoarthritis 45
Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function. 44
Chemotaxis and phagocytosis 44
Matrix metalloproteinase-2 enhances platelet deposition on collagen under flow conditions 43
Platelet-targeted pharmacologic treatments as anti-cancer therapy 43
Involvement of platelets in experimental mouse trypanosomiasis: evidence of mouse platelet cytotoxicity against Trypanosoma equiperdum. 42
NCX4016: a novel antithrombotic agent. 42
A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression. 41
Prevalence of hemostatic alterations in patients with recurrent spontaneous subconjunctival hemorrhage 41
Interactions of gallic acid, resveratrol, quercetin and aspirin at the platelet cyclooxygenase-1 level. Functional and modelling studies. 41
Prevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirin. 40
Low molecular weight heparins prevent thrombin-induced thromboembolism in mice despite low antithrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition. 39
A dichotomy in platelet activation: Evidence of different functional platelet responses to inflammatory versus haemostatic stimuli 39
Nitroaspirin plus clopidogrel versus aspirin plus clopidogrel against platelet thromboembolism and intimal thickening in mice 38
Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome. 37
Nitric oxide-enhancing or -releasing agents as antithrombotic drugs. 36
Trombocitopenia da eparina nel paziente dializzato 36
Platelets in respiratory disorders and inflammatory conditions. 35
Impaired thrombin-induced platelet activation and thrombus formation in mice lacking the Ca(2+)-dependent tyrosine kinase Pyk2. 35
Endogenous nitric oxide acts as a natural antithrombotic agent in vivo by inhibiting platelet aggregation in the pulmonary vasculature. 35
NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties. 34
Highly Active Antiretroviral Therapy-related Mechanisms of Endothelial and Platelets Function Alterations 34
HYPERGLYCEMIA-INDUCED PLATELET ACTIVATION IN TYPE 2 DIABETES MELLITUS IS RESISTANT TO ASPIRIN BUT NOT TO A NITRIC OXIDE-DONATING AGENT. 34
Matrix Metalloproteinases and Platelet Function 30
Platelets and chemotaxis. 29
Potentiation and priming of platelet activation: a potential target for antiplatelet therapy. 29
The effect of defibrotide on thromboembolism in the pulmonary vasculature of mice and rabbits and in the cerebral vasculature of rabbits 29
Role of Platelets in the Pathogenesis of Osteoarthritis and Biological Effects of Hyaluronic Acid: in Vivo and in Vitro Study 29
PCSK9 in Haemostasis and Thrombosis: Possible Pleiotropic Effects of PCSK9 Inhibitors in Cardiovascular Prevention 29
Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation. 28
Reperfusion of cerebral artery thrombosis by the GPIb-VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigs. 27
Stroke prevention: from available antiplatelet drugs to novel molecular targets. 21
Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis. 19
Matrix metalloproteinase-2 on activated platelets triggers endothelial PAR-1 initiating atherosclerosis 19
Platelet dysfunction in platelet-type von Willebrand disease due to the constitutive triggering of the Lyn-PECAM1 inhibitory pathway 17
Totale 2.855
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.907
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.907
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201918 0 0 0 0 0 0 0 0 0 0 14 4
2019/2020246 5 3 34 3 37 13 40 11 44 27 6 23
2020/2021522 4 34 14 40 156 24 44 2 51 15 46 92
2021/2022507 12 110 12 26 9 10 7 147 7 19 69 79
2022/20231.002 70 232 10 71 78 104 0 48 338 3 30 18
2023/2024301 19 42 18 5 2 4 99 9 46 12 45 0
Totale 2.855